Hospira, Inc. (HSP) Tops Q2 EPS by 16c; Guides FY14 EPS Above Consensus
Tweet
Share
E-mailGet Alerts HSP Hot Sheet
Price: $89.95 --0%
Financial Fact:
Income From Operations: 218.6M
Today's EPS Names:
OFLX, AFIB, NMRD, More
Financial Fact:
Income From Operations: 218.6M
Today's EPS Names:
OFLX, AFIB, NMRD, More
Join SI Premium – FREE
Hospira, Inc. (NYSE: HSP) reported Q2 EPS of $0.72, $0.16 better than the analyst estimate of $0.56. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.05 billion.
Hospira, Inc. sees FY2014 EPS of $2.30-$2.50, versus the consensus of $2.22.
For earnings history and earnings-related data on Hospira, Inc. (HSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
